Alzheimer’s Proteins Aβ42 and Tau Cause Distinct Whole-Body Changes in Fruit Fly Study
Summary: New research using Drosophila (fruit flies) shows that Alzheimer’s-associated proteins affect the entire organism—not just the brain. Scientists built an Alzheimer’s Disease Fly Cell Atlas (AD-FCA) that profiles gene expression across 219 cell types in the heads and bodies of adult flies expressing human Aβ42 or Tau in neurons. The study reveals that Aβ42 mainly damages neurons, especially sensory neurons, while neuronal Tau triggers broad peripheral defects that resemble accelerated aging.
Published in Neuron, this work expands our understanding of brain-body communication in neurodegeneration and creates a resource to discover biomarkers and potential therapeutic targets for Alzheimer’s disease.
Key findings:
- Whole-body impact: Neuron-specific expression of Aβ42 or Tau in adult flies produced changes not only in the nervous system but also in peripheral tissues across the body.
- Distinct tissue effects: Aβ42 predominantly harms the nervous system and is especially damaging to sensory neurons involved in smell, vision, and hearing. Tau expression in neurons produces wide-ranging peripheral alterations, including disrupted fat metabolism, impaired digestion and reduced fecundity.
- Accelerated aging signature: The changes associated with neuronal Tau resemble age-related decline, indicating Tau can accelerate aging-like processes in peripheral tissues.
- Conserved molecular signals: The team identified a neuronal cluster with high lactate dehydrogenase (LDH) expression enriched in Aβ42 flies; this LDH-high signature is also seen in mouse and human Alzheimer’s datasets. A conserved defect in fat metabolism appears in fly and mouse tauopathy models.
- New research tool: The AD Fly Cell Atlas (AD-FCA) catalogs single-nucleus transcriptomes from 219 cell types and is designed to enable whole-organism studies of Alzheimer’s-related effects and brain–body interactions.
Study approach and main results
To probe systemic effects of Alzheimer’s-associated proteins, the researchers used adult-only, neuron-specific expression of human Aβ42 peptide or human Tau in Drosophila. This strategy isolates the impact of these proteins on adult physiology and prevents developmental side effects from masking disease-relevant changes.
The team generated single-nucleus RNA-sequencing data from whole flies and compiled a Fly Cell Atlas covering 219 distinct cell types in head and body tissues. Comparing transcriptomes from control flies and those expressing Aβ42 or Tau revealed that Aβ42 primarily alters neuronal populations. Sensory neurons—those mediating olfaction, vision and audition—were particularly vulnerable, aligning with clinical observations that smell loss can be an early Alzheimer’s symptom.
In contrast, neuronal Tau triggered widespread disruptions outside the brain: altered lipid and energy metabolism, changes in digestive tissues and reduced reproductive output. These peripheral effects mirror aging-related decline, indicating that Tau expression in neurons compromises brain–body signaling and accelerates aging-like trajectories in other organs.
The researchers also detected an Aβ42-associated neuronal cluster with elevated lactate dehydrogenase (LDH) expression. This LDH-high population appears conserved in datasets from 5XFAD mouse models and human Alzheimer’s samples, suggesting a shared molecular response to amyloid pathology across species. Additionally, both fly and mouse tauopathy models showed consistent defects in fat metabolism, strengthening the case for conserved systemic mechanisms.
Implications for Alzheimer’s research and therapy
The AD Fly Cell Atlas provides a publicly accessible, high-resolution map of how Alzheimer’s-associated proteins differentially affect cell types throughout the organism. By revealing distinct systemic signatures for Aβ42 and Tau, the atlas helps prioritize cell populations and pathways for biomarker discovery and therapeutic intervention. It also underscores the importance of studying brain–body communication in neurodegeneration rather than focusing solely on neural tissue.
The resource is intended to support the neurodegeneration research community by enabling cross-species comparisons and follow-up functional studies aimed at reversing or preventing systemic decline driven by Alzheimer’s pathology.
Contributors, affiliations and funding
This project was led by scientists at Baylor College of Medicine and the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, in collaboration with teams at National Yang Ming Chiao Tung University (Taiwan), University of Michigan and U.T. Health San Antonio. Key contributors include Hongjie Li (co-corresponding author), Hugo Bellen (co-corresponding author), Ye-Jin Park, Tzu-Chiao Lu and many others.
Funding: The study was supported by multiple grants from NIH/NIA, NIH/NIGMS, OD R24 programs, the Huffington Foundation, the Duncan NRI endowment, a CPRIT scholarship and related awards that enabled the large-scale single-nucleus sequencing and analysis.
About this research news
Author: Homa Warren
Source: Baylor College of Medicine
Contact: Homa Warren – Baylor College of Medicine
Image: Image credit to Neuroscience News
Original research (open access): Distinct systemic impacts of Aβ42 and Tau revealed by whole-organism snRNA-seq, by Hongjie Li et al., published in Neuron.
Abstract (concise)
Distinct systemic impacts of Aβ42 and Tau revealed by whole-organism snRNA-seq
Alzheimer’s disease-related pathology disrupts both neuronal and peripheral tissues, but comprehensive whole-organism perspectives are limited. Using Drosophila, the AD Fly Cell Atlas (AD-FCA) profiles single-nucleus transcriptomes from 219 cell types in flies expressing neuron-specific Aβ42 or Tau. Aβ42 preferentially affects neuronal and sensory populations, while Tau induces accelerated aging signatures and metabolic defects in peripheral tissues. An LDH-high neuronal cluster enriched in Aβ42 flies is conserved in mouse and human datasets, and shared fat-metabolism defects are observed across fly and mouse tauopathy models. AD-FCA offers a valuable framework to study brain–body communication in neurodegeneration and to guide biomarker and therapeutic discovery.